The role of targeted biopsy methods in the prostate cancer diagnosis

Abstract

The current prostate cancer screening program results in unnecessary biopsies in a quarter of patients, overdiagnosis of clinically insignificant prostate cancer (ISUP 1) and overtreatment. Intoducing multiparametric magnetic resonance imaging into routine practice before biopsy allows to decrease the number of biopsies, thereby reducing the burden on clinicians and increasing the likelihood of detecting clinically significant forms of prostate cancer (ISUP >2).  The objective of this literature review is to compare targeted biopsy techniques and to determine their current role in the prostate cancer diagnosis.